Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/30/2025

Drug Interactions Between Fluoxetine and Quetiapine

Pharmacokinetic Interaction

  • Fluoxetine inhibits CYP2D6 and CYP3A4, though its effect on CYP3A4 is less potent than its effect on CYP2D6, according to the American Academy of Child and Adolescent Psychiatry 1

Serotonin Syndrome Risk

  • The American Academy of Child and Adolescent Psychiatry recommends exercising caution when combining fluoxetine and quetiapine, as the risk of serotonin syndrome is lower than with MAOIs or multiple serotonergic agents 2, 1
  • The combination of fluoxetine and quetiapine requires caution but not avoidance, as the serotonin syndrome risk is substantially lower than with MAOIs, according to the American Academy of Child and Adolescent Psychiatry 2, 1

Clinical Monitoring Strategy

  • The American Academy of Child and Adolescent Psychiatry suggests starting the second medication at a low dose and increasing slowly, monitoring particularly in the first 24-48 hours after any dosage changes 2, 3
  • Monitoring should include watching for serotonin syndrome symptoms, such as mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity, as recommended by the American Academy of Child and Adolescent Psychiatry 2, 1, 4

Additional Considerations

QT Prolongation

  • Both medications can affect cardiac conduction, though quetiapine's risk is generally lower than with some other antipsychotics, and consideration of baseline ECG in patients with cardiac risk factors is recommended when combining these medications 5
  • Fluoxetine may interact with drugs that prolong the QT interval, particularly at higher doses, according to the American Academy of Child and Adolescent Psychiatry 1

Bleeding Risk

  • Fluoxetine increases bleeding risk, especially with concomitant NSAIDs or antiplatelet agents, through effects on platelet serotonin, which is an SSRI class effect unrelated to the quetiapine combination, as noted by the American Academy of Child and Adolescent Psychiatry 2, 1